Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Helge L. Waldum, Øystein Sørdal & Reidar Fossmark. (2018) Proton pump inhibitors (PPIs) may cause gastric cancer – clinical consequences. Scandinavian Journal of Gastroenterology 53:6, pages 639-642.
Read now
Read now
Helge L. Waldum, Gunnar Qvigstad, Reidar Fossmark, Per M. Kleveland & Arne K. Sandvik. (2010) Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint. Scandinavian Journal of Gastroenterology 45:4, pages 389-394.
Read now
Read now
H. L. Waldum, R. Fossmark, I. Bakke, T. C. Martinsen & G. Qvigstad. (2004) Hypergastrinemia in animals and man: causes and consequences. Scandinavian Journal of Gastroenterology 39:6, pages 505-509.
Read now
Read now
Arne K Sandvik, Helge L Waldum & Eiliv Brenna. (2002) Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections. Expert Opinion on Drug Safety 1:1, pages 29-38.
Read now
Read now
Articles from other publishers (25)
A. Smirnova, N. Toktogulova, L. Atabaeva, T. Kalybekov & M. Dzhumabaev. (2024) A Systematic Review of Clinical Guidelines for the Treatment of Gastroesophageal Reflux Disease. Bulletin of Science and Practice 10:2, pages 155-171.
Crossref
Crossref
W. Köster & C. Scheffer. (2023) Bolus alba mit und ohne Gentiana lutea versus Protonenpumpenhemmer-Therapie bei nichterosiver Gastritis – Eine retrospektive Analyse. Der Merkurstab 76:2, pages 93-98.
Crossref
Crossref
Helge Waldum & Reidar Fossmark. (2021) Gastritis, Gastric Polyps and Gastric Cancer. International Journal of Molecular Sciences 22:12, pages 6548.
Crossref
Crossref
Helge L. Waldum, Øystein F. Sørdal & Patricia G. Mjønes. (2019) The Enterochromaffin-like [ECL] Cell—Central in Gastric Physiology and Pathology. International Journal of Molecular Sciences 20:10, pages 2444.
Crossref
Crossref
Karl Hermann Fuchs, Benjamin Babic, Wolfram Breithaupt, Bernard Dallemagne, Abe Fingerhut, Edgar Furnee, Frank Granderath, Peter Horvath, Peter Kardos, Rudolph Pointner, Edoardo Savarino, Maud Van Herwaarden-Lindeboom & Giovanni Zaninotto. (2014) EAES recommendations for the management of gastroesophageal reflux disease. Surgical Endoscopy 28:6, pages 1753-1773.
Crossref
Crossref
H. L. Waldum, Ø. Hauso & R. Fossmark. (2013) The regulation of gastric acid secretion – clinical perspectives. Acta Physiologica 210:2, pages 239-256.
Crossref
Crossref
Øystein Sørdal, Helge Waldum, Ivar S. Nordrum, Malcolm Boyce, Kåre Bergh, Bjørn Munkvold & Gunnar Qvigstad. (2013)
The Gastrin Receptor Antagonist Netazepide (
YF
476) Prevents Oxyntic Mucosal Inflammation Induced by
Helicobacter Pylori
Infection in Mongolian Gerbils
. Helicobacter 18:6, pages 397-405.
Crossref
Crossref
Malcolm Boyce & Steve Warrington. (2013) Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects. British Journal of Clinical Pharmacology 76:5, pages 680-688.
Crossref
Crossref
Helge L Waldum, Arne K Sandvik, Øyvind Hauso, Gunnar Qvigstad & Reidar Fossmark. (2012) Withdrawing PPI Therapy: Response to Metz et al.. American Journal of Gastroenterology 107:2, pages 325-326.
Crossref
Crossref
Christina Reimer, Bo Søndergaard, Linda Hilsted & Peter Bytzer. (2009) Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy. Gastroenterology 137:1, pages 80-87.e1.
Crossref
Crossref
M. Kidd, I.M. Modlin, J.W. Black, M. Boyce & M. Culler. (2007) A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation. Regulatory Peptides 143:1-3, pages 109-117.
Crossref
Crossref
Hiroshi Hashimoto, Tetsuya Kushikata, Mihoko Kudo & Kazuyoshi Hirota. (2007) Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?. Journal of Gastroenterology 42:4, pages 275-278.
Crossref
Crossref
Marian D Pfefferkorn, Joseph M Croffie, Sandeep K Gupta, Jean P Molleston, George J Eckert, Mark R Corkins & Joseph F Fitzgerald. (2006) Nocturnal Acid Breakthrough in Children with Reflux Esophagitis Taking Proton Pump Inhibitors. Journal of Pediatric Gastroenterology and Nutrition 42:2, pages 160-165.
Crossref
Crossref
Robert T. Jensen. (2006) Consequences of Long‐Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas. Basic & Clinical Pharmacology & Toxicology 98:1, pages 4-19.
Crossref
Crossref
A. Rackoff, A. Agrawal, A. Hila, I. Mainie, R. Tutuian & D. O. Castell. (2005) Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Diseases of the Esophagus 18:6, pages 370-373.
Crossref
Crossref
Kazuyoshi Hirota, Mihoko Kudo, Hiroshi Hashimoto & Tetsuya Kushikata. (2005) The Efficacy of Preanesthetic Proton Pump Inhibitor Treatment for Patients on Long-Term H2 Antagonist Therapy. Anesthesia & Analgesia 101:4, pages 1038-1041.
Crossref
Crossref
H. Osawa, H. Kita, H. Ohnishi, H. Mutoh, Y. Ishino, K. Satoh & K. Sugano. (2005)
Histamine‐2 receptor expression in gastric mucosa before and after
Helicobacter pylori
cure
. Alimentary Pharmacology & Therapeutics 21:s2, pages 92-98.
Crossref
Crossref
R. Fossmark, G. Johnsen, E. Johanessen & H. L. Waldum. (2004) Rebound acid hypersecretion after long‐term inhibition of gastric acid secretion. Alimentary Pharmacology & Therapeutics 21:2, pages 149-154.
Crossref
Crossref
Gunnar Qvigstad & Helge Waldum. (2004) Rebound Hypersecretion after Inhibition of Gastric Acid Secretion. Basic & Clinical Pharmacology & Toxicology 94:5, pages 202-208.
Crossref
Crossref
H. A. Risch. (2004) RESPONSE Re: Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric Acidity. JNCI Journal of the National Cancer Institute 96:1, pages 75-76.
Crossref
Crossref
K Hirota & T Kushikata. (2003) Editorial II. British Journal of Anaesthesia 90:5, pages 576-579.
Crossref
Crossref
William K. Fackler, Tina M. Ours, Michael F. Vaezi & Joel E. Richter. (2002) Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 122:3, pages 625-632.
Crossref
Crossref
Per G. Farup, P. H. Juul-Hansen & A. Rydning. (2001) Does Short-term Treatment With Proton Pump Inhibitors Cause Rebound Aggravation of Symptoms?. Journal of Clinical Gastroenterology 33:3, pages 206-209.
Crossref
Crossref
Kenneth E.L. McColl, Emad El-Omar & Derek Gillen. (2000) HELICOBACTER PYLORI GASTRITIS AND GASTRIC PHYSIOLOGY. Gastroenterology Clinics of North America 29:3, pages 687-703.
Crossref
Crossref
Waldum & Brenna. (2001) Personal review: is profound acid inhibition safe?. Alimentary Pharmacology & Therapeutics 14:1, pages 15-22.
Crossref
Crossref